Expert review of anti-infective therapy

Keyphrases

Publications

volume 22, number 5, 2024

Jack D Sobel
Treatment of vaginitis caused by non-albicans Candida species. Expert review of anti-infective therapy 22 (5) (2024)
Mengjun Tang, Chunhua Wang, Ying Xia, Jian Tang, Jiao Wang, Liang Shen
Clostridioides difficile infection in inflammatory bowel disease: a clinical review. Expert review of anti-infective therapy 22 (5) (2024)
Leonardo Lorente, Joan Sabater-Riera, Jordi Rello
Surveillance and prevention of healthcare-associated infections: best practices to prevent ventilator-associated events. Expert review of anti-infective therapy 22 (5) (2024)
Akihiro Ohmoto, Shigeo Fuji
Non-cancerous complications in HTLV-1 carriers. Expert review of anti-infective therapy 22 (5) (2024)
Jheng-Yen Wu, Mei-Yuan Liu, Mei-Chuan Lee, Kuo-Chuan Hung, Wan-Hsuan Hsu, Ya-Wen Tsai, Ting-Hui Liu, Po-Yu Huang, Min-Hsiang Chuang, Shu-Ching Tseng, Chih-Ying Lu, Chih-Cheng Lai
The clinical outcomes and effectiveness of antiviral agents among underweight patients with COVID-19. Expert review of anti-infective therapy 22 (5) (2024)
Vasso Apostolopoulos, Jack Feehan, Vivek P Chavda
How do we change our approach to COVID with the changing face of disease? Expert review of anti-infective therapy 22 (5) (2024)
Carl Llor, Ana Moragas
A multifaceted strategy is needed to limit the over-the-counter sale of antimicrobials. Expert review of anti-infective therapy 22 (5) (2024)
Lipin Lukose, Gursimran Kaur, Mohammed Asif M, Gail Ann Abraham, Kanav Khera, Viswam K Subeesh, Ronald L Castelino, Shubhada Karanth, Chandrashekar Udyavara Kudru, Muralidhar Varma, Sonal Sekhar Miraj
Predictors and patterns of empirical antibiotic therapy and associated outcomes in COVID-19 patients: a retrospective study in a tertiary care facility in South India. Expert review of anti-infective therapy 22 (5) (2024)
Lin Fan, Ming Yang, Yu-Tong Han, Fei Ren, Hua Wang, Jin-Bao Ma, Guo-Hui Zhu, Yan-Jun Xiong, Xin-Xin Fan, Su-Xia Chen, Hao-Yu Wu, Wen-Wen Sun, Shao-Jun Zhang, Hui Ke, Xiao-Hong Cheng, Biao Xu, Yu Chen, Chang Chen
Drug recommendation for optimization on treatment outcome for MDR/RR-TB based on a multi-center, large scale, retrospective cohort study in China. Expert review of anti-infective therapy 22 (5) (2024)
Jheng-Yen Wu, Mei-Yuan Liu, Mei-Chuan Lee, Kuo-Chuan Hung, Wan-Hsuan Hsu, Ya-Wen Tsai, Ting-Hui Liu, Po-Yu Huang, Min-Hsiang Chuang, Shu-Ching Tseng, Chih-Ying Lu, Chih-Cheng Lai
The clinical outcomes and effectiveness of antiviral agents among underweight patients with COVID-19. Expert review of anti-infective therapy 22 (5) (2024)
Lipin Lukose, Gursimran Kaur, Mohammed Asif M, Gail Ann Abraham, Kanav Khera, Viswam K Subeesh, Ronald L Castelino, Shubhada Karanth, Chandrashekar Udyavara Kudru, Muralidhar Varma, Sonal Sekhar Miraj
Predictors and patterns of empirical antibiotic therapy and associated outcomes in COVID-19 patients: a retrospective study in a tertiary care facility in South India. Expert review of anti-infective therapy 22 (5) (2024)
Anan S Jarab, Shrouq R Abu Heshmeh, Ahmad Z Al Meslamani
Biosimilars as antivirals: opportunities and challenges. Expert review of anti-infective therapy 22 (5) (2024)
Vasso Apostolopoulos, Jack Feehan, Vivek P Chavda
How do we change our approach to COVID with the changing face of disease? Expert review of anti-infective therapy 22 (5) (2024)
Leonardo Lorente, Joan Sabater-Riera, Jordi Rello
Surveillance and prevention of healthcare-associated infections: best practices to prevent ventilator-associated events. Expert review of anti-infective therapy 22 (5) (2024)
Akihiro Ohmoto, Shigeo Fuji
Non-cancerous complications in HTLV-1 carriers. Expert review of anti-infective therapy 22 (5) (2024)
Mengjun Tang, Chunhua Wang, Ying Xia, Jian Tang, Jiao Wang, Liang Shen
Clostridioides difficile infection in inflammatory bowel disease: a clinical review. Expert review of anti-infective therapy 22 (5) (2024)
Lin Fan, Ming Yang, Yu-Tong Han, Fei Ren, Hua Wang, Jin-Bao Ma, Guo-Hui Zhu, Yan-Jun Xiong, Xin-Xin Fan, Su-Xia Chen, Hao-Yu Wu, Wen-Wen Sun, Shao-Jun Zhang, Hui Ke, Xiao-Hong Cheng, Biao Xu, Yu Chen, Chang Chen
Drug recommendation for optimization on treatment outcome for MDR/RR-TB based on a multi-center, large scale, retrospective cohort study in China. Expert review of anti-infective therapy 22 (5) (2024)
Vasso Apostolopoulos, Jack Feehan, Vivek P Chavda
How do we change our approach to COVID with the changing face of disease? Expert review of anti-infective therapy 22 (5) (2024)
Leonardo Lorente, Joan Sabater-Riera, Jordi Rello
Surveillance and prevention of healthcare-associated infections: best practices to prevent ventilator-associated events. Expert review of anti-infective therapy 22 (5) (2024)
Mengjun Tang, Chunhua Wang, Ying Xia, Jian Tang, Jiao Wang, Liang Shen
Clostridioides difficile infection in inflammatory bowel disease: a clinical review. Expert review of anti-infective therapy 22 (5) (2024)
Carl Llor, Ana Moragas
A multifaceted strategy is needed to limit the over-the-counter sale of antimicrobials. Expert review of anti-infective therapy 22 (5) (2024)
Akihiro Ohmoto, Shigeo Fuji
Non-cancerous complications in HTLV-1 carriers. Expert review of anti-infective therapy 22 (5) (2024)
Jack D Sobel
Treatment of vaginitis caused by non-albicans Candida species. Expert review of anti-infective therapy 22 (5) (2024)
Anan S Jarab, Shrouq R Abu Heshmeh, Ahmad Z Al Meslamani
Biosimilars as antivirals: opportunities and challenges. Expert review of anti-infective therapy 22 (5) (2024)

volume 22, number 6, 2024

Pompeo Costantino Kouroupis, Niall O'Rourke, Sinead Kelly, Myles McKittrick, Elne Noppe, Luis F Reyes, Alejandro Rodriguez, Ignacio Martín-Loeches
Hospital-acquired bacterial pneumonia in critically ill patients: from research to clinical practice. Expert review of anti-infective therapy 22 (6) (2024)
Ahmad Z Al Meslamani
Is the world crippled by antimicrobial resistance, or simply lacking information? Expert review of anti-infective therapy 22 (6) (2024)
Muhammad Zeeshan Munir, Amer Hayat Khan, Tahir Mehmood Khan
Healthcare professionals' understanding and perception of drug-related issues linked to off-label pharmacological medications used for COVID-19. Expert review of anti-infective therapy 22 (6) (2024)
Rajeev Soman, Balaji Veeraraghavan, Ashit Hegde, Subhash Varma, Subhash Todi, R K Singh, Vasant Nagavekar, Camilla Rodrigues, Subramanian Swaminathan, V Ramsubramanian, Abdul Ansari, Dhruva Chaudhry, Amullya Pednekar, Sagar Bhagat, Saiprasad Patil, Hanmant Barkate
Indian consensus on the managemeNt of carbapenem-resistant enterobacterales infection in critically ill patients II (ICONIC II). Expert review of anti-infective therapy 22 (6) (2024)
Rajeev Soman, Balaji Veeraraghavan, Ashit Hegde, Subhash Varma, Subhash Todi, R K Singh, Vasant Nagavekar, Camilla Rodrigues, Subramanian Swaminathan, V Ramsubramanian, Abdul Ansari, Dhruva Chaudhry, Amullya Pednekar, Sagar Bhagat, Saiprasad Patil, Hanmant Barkate
Indian consensus on the managemeNt of carbapenem-resistant enterobacterales infection in critically ill patients II (ICONIC II). Expert review of anti-infective therapy 22 (6) (2024)
Susannah Franco, Margaret R Hammerschlag
Can we use azithromycin eye drops for gonococcal ophthalmia prophylaxis in the United States? Expert review of anti-infective therapy 22 (6) (2024)
Pulin Li, Ling Huang, Rui Han, Min Tang, Guanghe Fei, Daxiong Zeng, Ran Wang
Safety and efficacy of Paxlovid in the treatment of adults with mild to moderate COVID-19 during the omicron epidemic: a multicentre study from China. Expert review of anti-infective therapy 22 (6) (2024)
Niels Frimodt-Møller, Frederik Boetius Hertz
Antibiotic stewardship: following in the footsteps of Nordic countries? Expert review of anti-infective therapy 22 (6) (2024)
Aditya Kumar Gupta, Mesbah Talukder, Avner Shemer, Eran Galili
Safety and efficacy of new generation azole antifungals in the management of recalcitrant superficial fungal infections and onychomycosis. Expert review of anti-infective therapy 22 (6) (2024)
Muhammad Zeeshan Munir, Amer Hayat Khan, Tahir Mehmood Khan
Healthcare professionals' understanding and perception of drug-related issues linked to off-label pharmacological medications used for COVID-19. Expert review of anti-infective therapy 22 (6) (2024)
Soheil Sadr, Pouria Ahmadi Simab, Mahta Niazi, Zahra Yousefsani, Narges Lotfalizadeh, Ashkan Hajjafari, Hassan Borji
Anti-inflammatory and immunomodulatory effects of mesenchymal stem cell therapy on parasitic drug resistance. Expert review of anti-infective therapy 22 (6) (2024)
David Torres-Fernandez, Jessica Dalsuco, Justina Bramugy, Sozinho Acácio, Rosauro Varo
Innovative strategies for the surveillance, prevention, and management of pediatric infections applied to low-income settings. Expert review of anti-infective therapy 22 (6) (2024)
Pulin Li, Ling Huang, Rui Han, Min Tang, Guanghe Fei, Daxiong Zeng, Ran Wang
Safety and efficacy of Paxlovid in the treatment of adults with mild to moderate COVID-19 during the omicron epidemic: a multicentre study from China. Expert review of anti-infective therapy 22 (6) (2024)
Ahmad Z Al Meslamani
Is the world crippled by antimicrobial resistance, or simply lacking information? Expert review of anti-infective therapy 22 (6) (2024)
Aditya Kumar Gupta, Mesbah Talukder, Avner Shemer, Eran Galili
Safety and efficacy of new generation azole antifungals in the management of recalcitrant superficial fungal infections and onychomycosis. Expert review of anti-infective therapy 22 (6) (2024)
Aliyu Sulaiman, Mohammad Alfa Isah, Abubakar Usman
An assessment of the index of rational drug prescribing for severe acute respiratory infections among hospitalised children in Northern Nigeria: a retrospective study. Expert review of anti-infective therapy 22 (6) (2024)
Aliyu Sulaiman, Mohammad Alfa Isah, Abubakar Usman
An assessment of the index of rational drug prescribing for severe acute respiratory infections among hospitalised children in Northern Nigeria: a retrospective study. Expert review of anti-infective therapy 22 (6) (2024)
Po-Yu Huang, Chi-Kuei Hsu, Hung-Jen Tang, Chih-Cheng Lai
Eravacycline: a comprehensive review of in vitro activity, clinical efficacy, and real-world applications. Expert review of anti-infective therapy 22 (6) (2024)
Po-Yu Huang, Chi-Kuei Hsu, Hung-Jen Tang, Chih-Cheng Lai
Eravacycline: a comprehensive review of in vitro activity, clinical efficacy, and real-world applications. Expert review of anti-infective therapy 22 (6) (2024)
Soheil Sadr, Pouria Ahmadi Simab, Mahta Niazi, Zahra Yousefsani, Narges Lotfalizadeh, Ashkan Hajjafari, Hassan Borji
Anti-inflammatory and immunomodulatory effects of mesenchymal stem cell therapy on parasitic drug resistance. Expert review of anti-infective therapy 22 (6) (2024)
David Torres-Fernandez, Jessica Dalsuco, Justina Bramugy, Sozinho Acácio, Rosauro Varo
Innovative strategies for the surveillance, prevention, and management of pediatric infections applied to low-income settings. Expert review of anti-infective therapy 22 (6) (2024)
Susannah Franco, Margaret R Hammerschlag
Can we use azithromycin eye drops for gonococcal ophthalmia prophylaxis in the United States? Expert review of anti-infective therapy 22 (6) (2024)
Niels Frimodt-Møller, Frederik Boetius Hertz
Antibiotic stewardship: following in the footsteps of Nordic countries? Expert review of anti-infective therapy 22 (6) (2024)
Adriano Focus Lubanga, Akim Nelson Bwanali, Frank Kambiri, Gracian Harawa, Steward Mudenda, Samuel L Mpinganjira, Nathan Singano, Tumaini Makole, Thandizo Kapatsa, Mapeesho Kamayani, Stuart Ssebibubbu
Tackling antimicrobial resistance in sub-Saharan Africa: challenges and opportunities for implementing the new people-centered WHO guidelines. Expert review of anti-infective therapy 22 (6) (2024)
Adriano Focus Lubanga, Akim Nelson Bwanali, Frank Kambiri, Gracian Harawa, Steward Mudenda, Samuel L Mpinganjira, Nathan Singano, Tumaini Makole, Thandizo Kapatsa, Mapeesho Kamayani, Stuart Ssebibubbu
Tackling antimicrobial resistance in sub-Saharan Africa: challenges and opportunities for implementing the new people-centered WHO guidelines. Expert review of anti-infective therapy 22 (6) (2024)
Pompeo Costantino Kouroupis, Niall O'Rourke, Sinead Kelly, Myles McKittrick, Elne Noppe, Luis F Reyes, Alejandro Rodriguez, Ignacio Martín-Loeches
Hospital-acquired bacterial pneumonia in critically ill patients: from research to clinical practice. Expert review of anti-infective therapy 22 (6) (2024)